Search results
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to…
People make it happen. We are a collaborative group driven by the same goal: to create sustainable companies that translate scientific innovation to transform the lives of patients. We want to address our society’s greatest unmet medical needs; we are not afraid to do the difficult things.
We build our companies on a solid foundation, instilling core values and a commitment to great culture. Our companies are based on bold ideas that meet...
Third Rock Ventures | 44,002 followers on LinkedIn. We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine...
Third Rock Ventures has raised $3.8 billion since it was created and invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and Flare Therapeutics.
Jun 15, 2022 · Third Rock Ventures today announced the closing of Third Rock Ventures Fund VI, raising $1.1 billion. Fund VI will continue Third Rock’s core strategy.
Jun 18, 2024 · Third Rock’s Marea ropes in $190M to pioneer ‘the next frontier’ of cardiometabolic medicines. Marea Therapeutics has emerged with $190 million, a mid-stage clinical program and a plan to ...
